X4Oxygen Knowledge Hub
X4Oxygen
Knowledge Hub
Search...
Gain exclusive insights into the world of hyperbaric oxygen cambers and use cases.
This Knowledge Hub combines knowledge with expertise.
Important Notice / Disclaimer
The content on x4oxygen.com/knowledge is provided for informational and educational purposes only. It does not constitute medical, therapeutic, or advisory services and is in no way a substitute for professional advice, diagnosis, or treatment by qualified physicians, therapists, or other authorized healthcare professionals.
The information is based on publicly available sources and experiences and may vary depending on individual circumstances. X4Oxygen assumes no liability for any damage, injury, or adverse consequences that may arise from the use or application of the content shared here. Especially in the areas of oxygen therapy, health, and wellness, we strongly recommend consulting a physician before any application.
The content may be changed or updated without prior notice. X4Oxygen does not guarantee the completeness, accuracy, or timeliness of the information provided.
By using this website, you agree to these terms.
Gain exclusive insights into the world of hyperbaric oxygen cambers and use cases.
This Knowledge Hub combines knowledge with expertise.
Important Notice / Disclaimer
The content on x4oxygen.com/knowledge is provided for informational and educational purposes only. It does not constitute medical, therapeutic, or advisory services and is in no way a substitute for professional advice, diagnosis, or treatment by qualified physicians, therapists, or other authorized healthcare professionals.
The information is based on publicly available sources and experiences and may vary depending on individual circumstances. X4Oxygen assumes no liability for any damage, injury, or adverse consequences that may arise from the use or application of the content shared here. Especially in the areas of oxygen therapy, health, and wellness, we strongly recommend consulting a physician before any application.
The content may be changed or updated without prior notice. X4Oxygen does not guarantee the completeness, accuracy, or timeliness of the information provided.
By using this website, you agree to these terms.
Gain exclusive insights into the world of hyperbaric oxygen cambers and use cases.
This Knowledge Hub combines knowledge with expertise.
Important Notice / Disclaimer
The content on x4oxygen.com/knowledge is provided for informational and educational purposes only. It does not constitute medical, therapeutic, or advisory services and is in no way a substitute for professional advice, diagnosis, or treatment by qualified physicians, therapists, or other authorized healthcare professionals.
The information is based on publicly available sources and experiences and may vary depending on individual circumstances. X4Oxygen assumes no liability for any damage, injury, or adverse consequences that may arise from the use or application of the content shared here. Especially in the areas of oxygen therapy, health, and wellness, we strongly recommend consulting a physician before any application.
The content may be changed or updated without prior notice. X4Oxygen does not guarantee the completeness, accuracy, or timeliness of the information provided.
By using this website, you agree to these terms.
All Categories
Introduction
Clinical Studies
Guides & Training
Knowledge
Studies
2025 Study: HBOT Effects on Non-Motor Parkinson's Symptoms
HBOT reduces fatigue and depression (SMD -0.89); 7 studies (n=289); improves quality of life; dosage: 2 ATA, 20–40 sessions; minimal risks.
1
min reading time
Studies
A 5-year study (2020-2025) at the University of Zielona Góra, Poland, focuses on effective use cases for hyperbaric oxygen therapy.
Conclusions: HBOT is effective and safe for established indications such as radiation injury and chronic wounds.
10
min reading time
Studies
HBOT in Post-COVID and ME/CFS: Prospective Observational Study at Charité (NCT06118138)
Charité cohort (n=60): The course of ME/CFS after COVID under HBOT (2 ATA, 90 min) is being prospectively recorded. Primary endpoint: SF-36 PF ≥ +10 points at 4 weeks after completion of HBOT
10
min reading time
0
Studies
HIIT in Cancer: Better Fitness & Function Compared to Conventional Endurance Training?
HIIT improves function and VO₂ in cancer patients; compared to MICT, a benefit for VO₂ is observed (SMD 0.37; p=0.009). Training effects increase with total volume.
T. Neuendorf; R. Haase; S. Schroeder; M. Schumann; N. Nitzsche
10
min reading time
2023
Studies
HBOT can induce angiogenesis and restore erectile function.
HBOT (40 sessions, 2 ATA) significantly improves IIEF scores and increases penile perfusion (K-trans +153%); 80% report benefit. Findings suggest angiogenesis as the underlying mechanism.
Hadanny A; Lang E; Copel L; Meir O; Bechor Y; Fishlev G; Bergan J; Friedman M; Zisman A; Efrati S.
10
min reading time
2018
Studies
HBOT for the Reversal of Post-COVID Cognitive Impairment (Commentary)
Commentary: Hypoxemia Drives Post-COVID Cognitive Impairment. HBOT May Enhance Tissue Oxygenation & Neuroplasticity; Case Report and Small RCT Demonstrate Cognitive and MRI Improvements.
Chia Siang Kow; Dinesh S. Ramachandram; Syed S. Hasan
10
min reading time
2022
Studies
HBOT for the Treatment of Long COVID
The study investigates the use of hyperbaric oxygen therapy (HBOT) as a potential treatment for Long COVID.
Tim Robbins, Michael Gonevski, Cain Clark, Sudhanshu Baitule, Kavi Sharma, Angel Magar, Kiran Patel, Sailesh Sankar, Ioannis Kyrou, Asad Ali, Harpal S. Randeva.
10
min reading time
2021
Studies
HBOT Improves Neurocognitive Function and Post-COVID Symptoms
HBOT (40 sessions, 2 ATA, 90 min) improved cognition, energy, sleep, psychological symptoms, and pain in Long COVID; parallel improvements in brain perfusion and microstructure were observed.
Zilberman-Itskovich S, Catalogna M, Sasson E, Elman-Shina K, Hadanny A, Lang E, Finci S, Polak N, Fishlev G, Korin C, Shorer R, Parag Y, Sova M, Efrati S
1
min reading time
Studies
HBOT Reduces Vascular Dysfunction and Amyloid Burden (Alzheimer’s Mouse Model)
HBOT: CBF↑, hypoxia↓; in AD mice, amyloid↓. In elderly patients (n=6), CBF and cognitive scores improved after 60 sessions (2 ATA, 90 min).
Ronit Shapira; Amos Gdalyahu; Irit Gottfried; Efrat Sasson; Amir Hadanny; Shai Efrati; Pablo Blinder; Uri Ashery.
1
min reading time
Studies
HBOT can alleviate fibromyalgia syndrome
The study investigates the effects of hyperbaric oxygen therapy (HBOT) on telomere length and immune response in isolated blood cells.
Hachmo Y; Hadanny A; Abu Hamed R; Daniel-Kotovsky M; Catalogna M; Fishlev G; Lang E; Polak N; Doenyas K; Friedman M; Zemel Y; Bechor Y; Efrati S
10
min reading time
2020
Studies
HBOT Lengthens Telomeres and Reduces Immune Senescence in Older Adults (Prospective Study)
HBOT (60 sessions, 2 ATA) lengthens telomeres (>20%) in T, B, and NK cells and reduces senescent T cells (CD4⁺CD28⁻ −37%). Evidence of immunological rejuvenation.
Hachmo Y; Hadanny A; Abu Hamed R; Daniel-Kotovsky M; Catalogna M; Fishlev G; Lang E; Polak N; Doenyas K; Friedman M; Zemel Y; Bechor Y; Efrati S.
5
min reading time
2020
Studies
HBOT in Long COVID (HOT-LoCO): Interim Safety Analysis of a Randomized, Placebo-Controlled Trial
RCT interim analysis (n=20): No SAEs, 31 AEs/60% (mostly mild, cough/chest discomfort). DSMB assessed HBOT safety as favorable; baseline values in Long COVID markedly reduced.
Anders Kjellberg; Adrian Hassler; Emil Boström; Sara El Gharbi; Sarah Al-Ezerjawi; Jan Kowalski; Kenny A. Rodriguez-Wallberg; Judith Bruchfeld; Marcus Ståhlberg; Malin Nygren-Bonnier; Michael Runold; Peter Lindholm.
10
min reading time
2023
Studies
HBOT: From Mechanisms to Cognitive Enhancement (Review)
Review: Intermittent HBOT activates SIRT1/Nrf2/HIF-1α, improves CBF, metabolism & microstructure, and is associated with cognitive gains in stroke, TBI, MCI/AD, and healthy individuals.
Irit Gottfried; Nofar Schottlender; Uri Ashery.
1
min reading time
Studies
HBOT, Mitochondria & Oxidative Stress: What Does the Evidence Say?
Intermittent HBOT improves mitochondrial function and reduces oxidative stress: short-term ROS↑, long-term via Nrf2/SIRT1/HIF-1α antioxidant systems↑ and ROS↓.
Nofar Schottlender; Irit Gottfried; Uri Ashery
10
min reading time
2021
Studies
HBOT and Skin Aging: More Collagen, Longer Elastin Fibers, Less Senescence
This 2021 study explores how hyperbaric oxygen therapy affects skin aging by promoting collagen production, stimulating angiogenesis, and reducing cellular senescence.
Yafit Hachmo; Amir Hadanny; Sonia Mendelovic; Pnina Hillman; Eyal Shapira; Geva Landau; Hadar Gattegno; Avi Zrachya; Malka Daniel-Kotovsky; Merav Catalogna; Gregory Fishlev; Erez Lang; Nir Polak; Keren Doenyas; Mony Friedman; Yonatan Zemel; Yair Bechor; Shai Efrati
20
min reading time
2021
Studies
Hyperbaric Oxygen Therapy (HBOT) Alters Gene Expression in Seniors: Prospective Study
HBOT (60 sessions) markedly alters the blood transcriptome in seniors (1,912 genes). After 2 weeks, 19 genes remain affected, including ABCA13. Short-term dominant, partially lasting effect.
Amir Hadanny; Relly Forer; Dina Volodarsky; Malka Daniel-Kotovsky; Merav Catalogna; Yonatan Zemel; Yair Bechor; Shai Efrati
20
min reading time
Studies
HBOT increases telomere length and reduces immunosenescence in blood cells
HBOT (60 sessions) lengthens telomeres (>20%) in T, B and NK cells and reduces senescent T cells (−37% CD4⁺). Evidence of immunological rejuvenation.
Yafit Hachmo; Amir Hadanny; Ramzia Abu Hamed; Malka Daniel-Kotovsky; Merav Catalogna; Gregory Fishlev; Erez Lang; Nir Polak; Keren Doenyas; Mony Friedman; Yonatan Zemel; Yair Bechor; Shai Efrati
1
min reading time
All Categories
Introduction
Clinical Studies
Guides & Training
Knowledge
Studies
2025 Study: HBOT Effects on Non-Motor Parkinson's Symptoms
HBOT reduces fatigue and depression (SMD -0.89); 7 studies (n=289); improves quality of life; dosage: 2 ATA, 20–40 sessions; minimal risks.
1
min reading time
Studies
A 5-year study (2020-2025) at the University of Zielona Góra, Poland, focuses on effective use cases for hyperbaric oxygen therapy.
Conclusions: HBOT is effective and safe for established indications such as radiation injury and chronic wounds.
10
min reading time
Studies
HBOT in Post-COVID and ME/CFS: Prospective Observational Study at Charité (NCT06118138)
Charité cohort (n=60): The course of ME/CFS after COVID under HBOT (2 ATA, 90 min) is being prospectively recorded. Primary endpoint: SF-36 PF ≥ +10 points at 4 weeks after completion of HBOT
10
min reading time
0
Studies
HIIT in Cancer: Better Fitness & Function Compared to Conventional Endurance Training?
HIIT improves function and VO₂ in cancer patients; compared to MICT, a benefit for VO₂ is observed (SMD 0.37; p=0.009). Training effects increase with total volume.
T. Neuendorf; R. Haase; S. Schroeder; M. Schumann; N. Nitzsche
10
min reading time
2023
Studies
HBOT can induce angiogenesis and restore erectile function.
HBOT (40 sessions, 2 ATA) significantly improves IIEF scores and increases penile perfusion (K-trans +153%); 80% report benefit. Findings suggest angiogenesis as the underlying mechanism.
Hadanny A; Lang E; Copel L; Meir O; Bechor Y; Fishlev G; Bergan J; Friedman M; Zisman A; Efrati S.
10
min reading time
2018
Studies
HBOT for the Reversal of Post-COVID Cognitive Impairment (Commentary)
Commentary: Hypoxemia Drives Post-COVID Cognitive Impairment. HBOT May Enhance Tissue Oxygenation & Neuroplasticity; Case Report and Small RCT Demonstrate Cognitive and MRI Improvements.
Chia Siang Kow; Dinesh S. Ramachandram; Syed S. Hasan
10
min reading time
2022
Studies
HBOT for the Treatment of Long COVID
The study investigates the use of hyperbaric oxygen therapy (HBOT) as a potential treatment for Long COVID.
Tim Robbins, Michael Gonevski, Cain Clark, Sudhanshu Baitule, Kavi Sharma, Angel Magar, Kiran Patel, Sailesh Sankar, Ioannis Kyrou, Asad Ali, Harpal S. Randeva.
10
min reading time
2021
Studies
HBOT Improves Neurocognitive Function and Post-COVID Symptoms
HBOT (40 sessions, 2 ATA, 90 min) improved cognition, energy, sleep, psychological symptoms, and pain in Long COVID; parallel improvements in brain perfusion and microstructure were observed.
Zilberman-Itskovich S, Catalogna M, Sasson E, Elman-Shina K, Hadanny A, Lang E, Finci S, Polak N, Fishlev G, Korin C, Shorer R, Parag Y, Sova M, Efrati S
1
min reading time
Studies
HBOT Reduces Vascular Dysfunction and Amyloid Burden (Alzheimer’s Mouse Model)
HBOT: CBF↑, hypoxia↓; in AD mice, amyloid↓. In elderly patients (n=6), CBF and cognitive scores improved after 60 sessions (2 ATA, 90 min).
Ronit Shapira; Amos Gdalyahu; Irit Gottfried; Efrat Sasson; Amir Hadanny; Shai Efrati; Pablo Blinder; Uri Ashery.
1
min reading time
Studies
HBOT can alleviate fibromyalgia syndrome
The study investigates the effects of hyperbaric oxygen therapy (HBOT) on telomere length and immune response in isolated blood cells.
Hachmo Y; Hadanny A; Abu Hamed R; Daniel-Kotovsky M; Catalogna M; Fishlev G; Lang E; Polak N; Doenyas K; Friedman M; Zemel Y; Bechor Y; Efrati S
10
min reading time
2020
Studies
HBOT Lengthens Telomeres and Reduces Immune Senescence in Older Adults (Prospective Study)
HBOT (60 sessions, 2 ATA) lengthens telomeres (>20%) in T, B, and NK cells and reduces senescent T cells (CD4⁺CD28⁻ −37%). Evidence of immunological rejuvenation.
Hachmo Y; Hadanny A; Abu Hamed R; Daniel-Kotovsky M; Catalogna M; Fishlev G; Lang E; Polak N; Doenyas K; Friedman M; Zemel Y; Bechor Y; Efrati S.
5
min reading time
2020
Studies
HBOT in Long COVID (HOT-LoCO): Interim Safety Analysis of a Randomized, Placebo-Controlled Trial
RCT interim analysis (n=20): No SAEs, 31 AEs/60% (mostly mild, cough/chest discomfort). DSMB assessed HBOT safety as favorable; baseline values in Long COVID markedly reduced.
Anders Kjellberg; Adrian Hassler; Emil Boström; Sara El Gharbi; Sarah Al-Ezerjawi; Jan Kowalski; Kenny A. Rodriguez-Wallberg; Judith Bruchfeld; Marcus Ståhlberg; Malin Nygren-Bonnier; Michael Runold; Peter Lindholm.
10
min reading time
2023
Studies
HBOT: From Mechanisms to Cognitive Enhancement (Review)
Review: Intermittent HBOT activates SIRT1/Nrf2/HIF-1α, improves CBF, metabolism & microstructure, and is associated with cognitive gains in stroke, TBI, MCI/AD, and healthy individuals.
Irit Gottfried; Nofar Schottlender; Uri Ashery.
1
min reading time
Studies
HBOT, Mitochondria & Oxidative Stress: What Does the Evidence Say?
Intermittent HBOT improves mitochondrial function and reduces oxidative stress: short-term ROS↑, long-term via Nrf2/SIRT1/HIF-1α antioxidant systems↑ and ROS↓.
Nofar Schottlender; Irit Gottfried; Uri Ashery
10
min reading time
2021
Studies
HBOT and Skin Aging: More Collagen, Longer Elastin Fibers, Less Senescence
This 2021 study explores how hyperbaric oxygen therapy affects skin aging by promoting collagen production, stimulating angiogenesis, and reducing cellular senescence.
Yafit Hachmo; Amir Hadanny; Sonia Mendelovic; Pnina Hillman; Eyal Shapira; Geva Landau; Hadar Gattegno; Avi Zrachya; Malka Daniel-Kotovsky; Merav Catalogna; Gregory Fishlev; Erez Lang; Nir Polak; Keren Doenyas; Mony Friedman; Yonatan Zemel; Yair Bechor; Shai Efrati
20
min reading time
2021
Studies
Hyperbaric Oxygen Therapy (HBOT) Alters Gene Expression in Seniors: Prospective Study
HBOT (60 sessions) markedly alters the blood transcriptome in seniors (1,912 genes). After 2 weeks, 19 genes remain affected, including ABCA13. Short-term dominant, partially lasting effect.
Amir Hadanny; Relly Forer; Dina Volodarsky; Malka Daniel-Kotovsky; Merav Catalogna; Yonatan Zemel; Yair Bechor; Shai Efrati
20
min reading time
Studies
HBOT increases telomere length and reduces immunosenescence in blood cells
HBOT (60 sessions) lengthens telomeres (>20%) in T, B and NK cells and reduces senescent T cells (−37% CD4⁺). Evidence of immunological rejuvenation.
Yafit Hachmo; Amir Hadanny; Ramzia Abu Hamed; Malka Daniel-Kotovsky; Merav Catalogna; Gregory Fishlev; Erez Lang; Nir Polak; Keren Doenyas; Mony Friedman; Yonatan Zemel; Yair Bechor; Shai Efrati
1
min reading time
Studies
2025 Study: HBOT Effects on Non-Motor Parkinson's Symptoms
HBOT reduces fatigue and depression (SMD -0.89); 7 studies (n=289); improves quality of life; dosage: 2 ATA, 20–40 sessions; minimal risks.
1
min reading time
Studies
A 5-year study (2020-2025) at the University of Zielona Góra, Poland, focuses on effective use cases for hyperbaric oxygen therapy.
Conclusions: HBOT is effective and safe for established indications such as radiation injury and chronic wounds.
10
min reading time
Studies
HBOT in Post-COVID and ME/CFS: Prospective Observational Study at Charité (NCT06118138)
Charité cohort (n=60): The course of ME/CFS after COVID under HBOT (2 ATA, 90 min) is being prospectively recorded. Primary endpoint: SF-36 PF ≥ +10 points at 4 weeks after completion of HBOT
10
min reading time
0
Studies
HIIT in Cancer: Better Fitness & Function Compared to Conventional Endurance Training?
HIIT improves function and VO₂ in cancer patients; compared to MICT, a benefit for VO₂ is observed (SMD 0.37; p=0.009). Training effects increase with total volume.
T. Neuendorf; R. Haase; S. Schroeder; M. Schumann; N. Nitzsche
10
min reading time
2023
Studies
HBOT can induce angiogenesis and restore erectile function.
HBOT (40 sessions, 2 ATA) significantly improves IIEF scores and increases penile perfusion (K-trans +153%); 80% report benefit. Findings suggest angiogenesis as the underlying mechanism.
Hadanny A; Lang E; Copel L; Meir O; Bechor Y; Fishlev G; Bergan J; Friedman M; Zisman A; Efrati S.
10
min reading time
2018
Studies
HBOT for the Reversal of Post-COVID Cognitive Impairment (Commentary)
Commentary: Hypoxemia Drives Post-COVID Cognitive Impairment. HBOT May Enhance Tissue Oxygenation & Neuroplasticity; Case Report and Small RCT Demonstrate Cognitive and MRI Improvements.
Chia Siang Kow; Dinesh S. Ramachandram; Syed S. Hasan
10
min reading time
2022
Studies
HBOT for the Treatment of Long COVID
The study investigates the use of hyperbaric oxygen therapy (HBOT) as a potential treatment for Long COVID.
Tim Robbins, Michael Gonevski, Cain Clark, Sudhanshu Baitule, Kavi Sharma, Angel Magar, Kiran Patel, Sailesh Sankar, Ioannis Kyrou, Asad Ali, Harpal S. Randeva.
10
min reading time
2021
Studies
HBOT Improves Neurocognitive Function and Post-COVID Symptoms
HBOT (40 sessions, 2 ATA, 90 min) improved cognition, energy, sleep, psychological symptoms, and pain in Long COVID; parallel improvements in brain perfusion and microstructure were observed.
Zilberman-Itskovich S, Catalogna M, Sasson E, Elman-Shina K, Hadanny A, Lang E, Finci S, Polak N, Fishlev G, Korin C, Shorer R, Parag Y, Sova M, Efrati S
1
min reading time
Studies
HBOT Reduces Vascular Dysfunction and Amyloid Burden (Alzheimer’s Mouse Model)
HBOT: CBF↑, hypoxia↓; in AD mice, amyloid↓. In elderly patients (n=6), CBF and cognitive scores improved after 60 sessions (2 ATA, 90 min).
Ronit Shapira; Amos Gdalyahu; Irit Gottfried; Efrat Sasson; Amir Hadanny; Shai Efrati; Pablo Blinder; Uri Ashery.
1
min reading time
Studies
HBOT can alleviate fibromyalgia syndrome
The study investigates the effects of hyperbaric oxygen therapy (HBOT) on telomere length and immune response in isolated blood cells.
Hachmo Y; Hadanny A; Abu Hamed R; Daniel-Kotovsky M; Catalogna M; Fishlev G; Lang E; Polak N; Doenyas K; Friedman M; Zemel Y; Bechor Y; Efrati S
10
min reading time
2020
Studies
HBOT Lengthens Telomeres and Reduces Immune Senescence in Older Adults (Prospective Study)
HBOT (60 sessions, 2 ATA) lengthens telomeres (>20%) in T, B, and NK cells and reduces senescent T cells (CD4⁺CD28⁻ −37%). Evidence of immunological rejuvenation.
Hachmo Y; Hadanny A; Abu Hamed R; Daniel-Kotovsky M; Catalogna M; Fishlev G; Lang E; Polak N; Doenyas K; Friedman M; Zemel Y; Bechor Y; Efrati S.
5
min reading time
2020
Studies
HBOT in Long COVID (HOT-LoCO): Interim Safety Analysis of a Randomized, Placebo-Controlled Trial
RCT interim analysis (n=20): No SAEs, 31 AEs/60% (mostly mild, cough/chest discomfort). DSMB assessed HBOT safety as favorable; baseline values in Long COVID markedly reduced.
Anders Kjellberg; Adrian Hassler; Emil Boström; Sara El Gharbi; Sarah Al-Ezerjawi; Jan Kowalski; Kenny A. Rodriguez-Wallberg; Judith Bruchfeld; Marcus Ståhlberg; Malin Nygren-Bonnier; Michael Runold; Peter Lindholm.
10
min reading time
2023
Studies
HBOT: From Mechanisms to Cognitive Enhancement (Review)
Review: Intermittent HBOT activates SIRT1/Nrf2/HIF-1α, improves CBF, metabolism & microstructure, and is associated with cognitive gains in stroke, TBI, MCI/AD, and healthy individuals.
Irit Gottfried; Nofar Schottlender; Uri Ashery.
1
min reading time
Studies
HBOT, Mitochondria & Oxidative Stress: What Does the Evidence Say?
Intermittent HBOT improves mitochondrial function and reduces oxidative stress: short-term ROS↑, long-term via Nrf2/SIRT1/HIF-1α antioxidant systems↑ and ROS↓.
Nofar Schottlender; Irit Gottfried; Uri Ashery
10
min reading time
2021
Studies
HBOT and Skin Aging: More Collagen, Longer Elastin Fibers, Less Senescence
This 2021 study explores how hyperbaric oxygen therapy affects skin aging by promoting collagen production, stimulating angiogenesis, and reducing cellular senescence.
Yafit Hachmo; Amir Hadanny; Sonia Mendelovic; Pnina Hillman; Eyal Shapira; Geva Landau; Hadar Gattegno; Avi Zrachya; Malka Daniel-Kotovsky; Merav Catalogna; Gregory Fishlev; Erez Lang; Nir Polak; Keren Doenyas; Mony Friedman; Yonatan Zemel; Yair Bechor; Shai Efrati
20
min reading time
2021
Studies
Hyperbaric Oxygen Therapy (HBOT) Alters Gene Expression in Seniors: Prospective Study
HBOT (60 sessions) markedly alters the blood transcriptome in seniors (1,912 genes). After 2 weeks, 19 genes remain affected, including ABCA13. Short-term dominant, partially lasting effect.
Amir Hadanny; Relly Forer; Dina Volodarsky; Malka Daniel-Kotovsky; Merav Catalogna; Yonatan Zemel; Yair Bechor; Shai Efrati
20
min reading time
Studies
HBOT increases telomere length and reduces immunosenescence in blood cells
HBOT (60 sessions) lengthens telomeres (>20%) in T, B and NK cells and reduces senescent T cells (−37% CD4⁺). Evidence of immunological rejuvenation.
Yafit Hachmo; Amir Hadanny; Ramzia Abu Hamed; Malka Daniel-Kotovsky; Merav Catalogna; Gregory Fishlev; Erez Lang; Nir Polak; Keren Doenyas; Mony Friedman; Yonatan Zemel; Yair Bechor; Shai Efrati
1
min reading time
X4 Innovation © 2025 All Rights reserved
X4 Innovation © 2025 All Rights reserved
X4 Innovation © 2025 All Rights reserved